Company news

ENDRA Life Sciences Inc. news in 2025

ENDRA Life Sciences Inc.'s news releases, calls and decks from 2025, newest first.

View company

ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active

December 9, 2025

ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

December 4, 2025

ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform

December 2, 2025

ENDRA Life Sciences (NASDAQ: NDRA) Advances "Yield-to-Innovation" Strategy to Accelerate Breakthrough Liver Imaging Technology

November 25, 2025

ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

November 20, 2025

ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

November 17, 2025

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

November 12, 2025

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

October 22, 2025

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

October 12, 2025

ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

August 14, 2025

ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

June 16, 2025

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

May 15, 2025

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

March 31, 2025

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

March 31, 2025

Decks in 2025